Global Biodefense Market Research Report 2026(Status and Outlook)
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country?s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
The global Biodefense market size was estimated at USD 1316.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biodefense market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biodefense market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biodefense market.
Global Biodefense Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Market Segmentation (by Type)
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market Segmentation (by Application)
US Military Market
US Civilian Market
Non - US Market
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biodefense Market
Overview of the regional outlook of the Biodefense Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biodefense Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biodefense, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Biodefense market size was estimated at USD 1316.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biodefense market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biodefense market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biodefense market.
Global Biodefense Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Market Segmentation (by Type)
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market Segmentation (by Application)
US Military Market
US Civilian Market
Non - US Market
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biodefense Market
Overview of the regional outlook of the Biodefense Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biodefense Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biodefense, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biodefense
1.2 Key Market Segments
1.2.1 Biodefense Segment by Type
1.2.2 Biodefense Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIODEFENSE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biodefense Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biodefense Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIODEFENSE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biodefense Product Life Cycle
3.3 Global Biodefense Sales by Manufacturers (2020-2025)
3.4 Global Biodefense Revenue Market Share by Manufacturers (2020-2025)
3.5 Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biodefense Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biodefense Market Competitive Situation and Trends
3.8.1 Biodefense Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biodefense Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIODEFENSE INDUSTRY CHAIN ANALYSIS
4.1 Biodefense Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIODEFENSE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biodefense Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biodefense Market
5.7 ESG Ratings of Leading Companies
6 BIODEFENSE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biodefense Sales Market Share by Type (2020-2025)
6.3 Global Biodefense Market Size by Type (2020-2025)
6.4 Global Biodefense Price by Type (2020-2025)
7 BIODEFENSE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biodefense Market Sales by Application (2020-2025)
7.3 Global Biodefense Market Size (M USD) by Application (2020-2025)
7.4 Global Biodefense Sales Growth Rate by Application (2020-2025)
8 BIODEFENSE MARKET SALES BY REGION
8.1 Global Biodefense Sales by Region
8.1.1 Global Biodefense Sales by Region
8.1.2 Global Biodefense Sales Market Share by Region
8.2 Global Biodefense Market Size by Region
8.2.1 Global Biodefense Market Size by Region
8.2.2 Global Biodefense Market Size by Region
8.3 North America
8.3.1 North America Biodefense Sales by Country
8.3.2 North America Biodefense Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biodefense Sales by Country
8.4.2 Europe Biodefense Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biodefense Sales by Region
8.5.2 Asia Pacific Biodefense Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biodefense Sales by Country
8.6.2 South America Biodefense Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biodefense Sales by Region
8.7.2 Middle East and Africa Biodefense Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIODEFENSE MARKET PRODUCTION BY REGION
9.1 Global Production of Biodefense by Region(2020-2025)
9.2 Global Biodefense Revenue Market Share by Region (2020-2025)
9.3 Global Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biodefense Production
9.4.1 North America Biodefense Production Growth Rate (2020-2025)
9.4.2 North America Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biodefense Production
9.5.1 Europe Biodefense Production Growth Rate (2020-2025)
9.5.2 Europe Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biodefense Production (2020-2025)
9.6.1 Japan Biodefense Production Growth Rate (2020-2025)
9.6.2 Japan Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biodefense Production (2020-2025)
9.7.1 China Biodefense Production Growth Rate (2020-2025)
9.7.2 China Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emergent Biosolutions
10.1.1 Emergent Biosolutions Basic Information
10.1.2 Emergent Biosolutions Biodefense Product Overview
10.1.3 Emergent Biosolutions Biodefense Product Market Performance
10.1.4 Emergent Biosolutions Business Overview
10.1.5 Emergent Biosolutions SWOT Analysis
10.1.6 Emergent Biosolutions Recent Developments
10.2 Hytest
10.2.1 Hytest Basic Information
10.2.2 Hytest Biodefense Product Overview
10.2.3 Hytest Biodefense Product Market Performance
10.2.4 Hytest Business Overview
10.2.5 Hytest SWOT Analysis
10.2.6 Hytest Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Biodefense Product Overview
10.3.3 GSK Biodefense Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Biodefense Product Overview
10.4.3 Sanofi Biodefense Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 PharmAthene
10.5.1 PharmAthene Basic Information
10.5.2 PharmAthene Biodefense Product Overview
10.5.3 PharmAthene Biodefense Product Market Performance
10.5.4 PharmAthene Business Overview
10.5.5 PharmAthene Recent Developments
10.6 Bavarian Nordic
10.6.1 Bavarian Nordic Basic Information
10.6.2 Bavarian Nordic Biodefense Product Overview
10.6.3 Bavarian Nordic Biodefense Product Market Performance
10.6.4 Bavarian Nordic Business Overview
10.6.5 Bavarian Nordic Recent Developments
10.7 SIGA Technologies
10.7.1 SIGA Technologies Basic Information
10.7.2 SIGA Technologies Biodefense Product Overview
10.7.3 SIGA Technologies Biodefense Product Market Performance
10.7.4 SIGA Technologies Business Overview
10.7.5 SIGA Technologies Recent Developments
10.8 Arbutus Biopharma
10.8.1 Arbutus Biopharma Basic Information
10.8.2 Arbutus Biopharma Biodefense Product Overview
10.8.3 Arbutus Biopharma Biodefense Product Market Performance
10.8.4 Arbutus Biopharma Business Overview
10.8.5 Arbutus Biopharma Recent Developments
10.9 DynPort Vaccine
10.9.1 DynPort Vaccine Basic Information
10.9.2 DynPort Vaccine Biodefense Product Overview
10.9.3 DynPort Vaccine Biodefense Product Market Performance
10.9.4 DynPort Vaccine Business Overview
10.9.5 DynPort Vaccine Recent Developments
10.10 Xoma Corporation
10.10.1 Xoma Corporation Basic Information
10.10.2 Xoma Corporation Biodefense Product Overview
10.10.3 Xoma Corporation Biodefense Product Market Performance
10.10.4 Xoma Corporation Business Overview
10.10.5 Xoma Corporation Recent Developments
10.11 Ichor Medical Systems
10.11.1 Ichor Medical Systems Basic Information
10.11.2 Ichor Medical Systems Biodefense Product Overview
10.11.3 Ichor Medical Systems Biodefense Product Market Performance
10.11.4 Ichor Medical Systems Business Overview
10.11.5 Ichor Medical Systems Recent Developments
10.12 Aeolus Pharmaceuticals
10.12.1 Aeolus Pharmaceuticals Basic Information
10.12.2 Aeolus Pharmaceuticals Biodefense Product Overview
10.12.3 Aeolus Pharmaceuticals Biodefense Product Market Performance
10.12.4 Aeolus Pharmaceuticals Business Overview
10.12.5 Aeolus Pharmaceuticals Recent Developments
10.13 Achaogen
10.13.1 Achaogen Basic Information
10.13.2 Achaogen Biodefense Product Overview
10.13.3 Achaogen Biodefense Product Market Performance
10.13.4 Achaogen Business Overview
10.13.5 Achaogen Recent Developments
10.14 Elusys Therapeutics
10.14.1 Elusys Therapeutics Basic Information
10.14.2 Elusys Therapeutics Biodefense Product Overview
10.14.3 Elusys Therapeutics Biodefense Product Market Performance
10.14.4 Elusys Therapeutics Business Overview
10.14.5 Elusys Therapeutics Recent Developments
10.15 Dynavax Technologies
10.15.1 Dynavax Technologies Basic Information
10.15.2 Dynavax Technologies Biodefense Product Overview
10.15.3 Dynavax Technologies Biodefense Product Market Performance
10.15.4 Dynavax Technologies Business Overview
10.15.5 Dynavax Technologies Recent Developments
10.16 Cleveland BioLabs
10.16.1 Cleveland BioLabs Basic Information
10.16.2 Cleveland BioLabs Biodefense Product Overview
10.16.3 Cleveland BioLabs Biodefense Product Market Performance
10.16.4 Cleveland BioLabs Business Overview
10.16.5 Cleveland BioLabs Recent Developments
10.17 Soligenix
10.17.1 Soligenix Basic Information
10.17.2 Soligenix Biodefense Product Overview
10.17.3 Soligenix Biodefense Product Market Performance
10.17.4 Soligenix Business Overview
10.17.5 Soligenix Recent Developments
10.18 Alnylam Pharmaceuticals
10.18.1 Alnylam Pharmaceuticals Basic Information
10.18.2 Alnylam Pharmaceuticals Biodefense Product Overview
10.18.3 Alnylam Pharmaceuticals Biodefense Product Market Performance
10.18.4 Alnylam Pharmaceuticals Business Overview
10.18.5 Alnylam Pharmaceuticals Recent Developments
11 BIODEFENSE MARKET FORECAST BY REGION
11.1 Global Biodefense Market Size Forecast
11.2 Global Biodefense Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biodefense Market Size Forecast by Country
11.2.3 Asia Pacific Biodefense Market Size Forecast by Region
11.2.4 South America Biodefense Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biodefense by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biodefense Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biodefense by Type (2026-2035)
12.1.2 Global Biodefense Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biodefense by Type (2026-2035)
12.2 Global Biodefense Market Forecast by Application (2026-2035)
12.2.1 Global Biodefense Sales (K MT) Forecast by Application
12.2.2 Global Biodefense Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biodefense
1.2 Key Market Segments
1.2.1 Biodefense Segment by Type
1.2.2 Biodefense Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIODEFENSE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biodefense Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biodefense Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIODEFENSE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biodefense Product Life Cycle
3.3 Global Biodefense Sales by Manufacturers (2020-2025)
3.4 Global Biodefense Revenue Market Share by Manufacturers (2020-2025)
3.5 Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biodefense Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biodefense Market Competitive Situation and Trends
3.8.1 Biodefense Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biodefense Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIODEFENSE INDUSTRY CHAIN ANALYSIS
4.1 Biodefense Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIODEFENSE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biodefense Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biodefense Market
5.7 ESG Ratings of Leading Companies
6 BIODEFENSE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biodefense Sales Market Share by Type (2020-2025)
6.3 Global Biodefense Market Size by Type (2020-2025)
6.4 Global Biodefense Price by Type (2020-2025)
7 BIODEFENSE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biodefense Market Sales by Application (2020-2025)
7.3 Global Biodefense Market Size (M USD) by Application (2020-2025)
7.4 Global Biodefense Sales Growth Rate by Application (2020-2025)
8 BIODEFENSE MARKET SALES BY REGION
8.1 Global Biodefense Sales by Region
8.1.1 Global Biodefense Sales by Region
8.1.2 Global Biodefense Sales Market Share by Region
8.2 Global Biodefense Market Size by Region
8.2.1 Global Biodefense Market Size by Region
8.2.2 Global Biodefense Market Size by Region
8.3 North America
8.3.1 North America Biodefense Sales by Country
8.3.2 North America Biodefense Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biodefense Sales by Country
8.4.2 Europe Biodefense Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biodefense Sales by Region
8.5.2 Asia Pacific Biodefense Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biodefense Sales by Country
8.6.2 South America Biodefense Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biodefense Sales by Region
8.7.2 Middle East and Africa Biodefense Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIODEFENSE MARKET PRODUCTION BY REGION
9.1 Global Production of Biodefense by Region(2020-2025)
9.2 Global Biodefense Revenue Market Share by Region (2020-2025)
9.3 Global Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biodefense Production
9.4.1 North America Biodefense Production Growth Rate (2020-2025)
9.4.2 North America Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biodefense Production
9.5.1 Europe Biodefense Production Growth Rate (2020-2025)
9.5.2 Europe Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biodefense Production (2020-2025)
9.6.1 Japan Biodefense Production Growth Rate (2020-2025)
9.6.2 Japan Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biodefense Production (2020-2025)
9.7.1 China Biodefense Production Growth Rate (2020-2025)
9.7.2 China Biodefense Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emergent Biosolutions
10.1.1 Emergent Biosolutions Basic Information
10.1.2 Emergent Biosolutions Biodefense Product Overview
10.1.3 Emergent Biosolutions Biodefense Product Market Performance
10.1.4 Emergent Biosolutions Business Overview
10.1.5 Emergent Biosolutions SWOT Analysis
10.1.6 Emergent Biosolutions Recent Developments
10.2 Hytest
10.2.1 Hytest Basic Information
10.2.2 Hytest Biodefense Product Overview
10.2.3 Hytest Biodefense Product Market Performance
10.2.4 Hytest Business Overview
10.2.5 Hytest SWOT Analysis
10.2.6 Hytest Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Biodefense Product Overview
10.3.3 GSK Biodefense Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Biodefense Product Overview
10.4.3 Sanofi Biodefense Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 PharmAthene
10.5.1 PharmAthene Basic Information
10.5.2 PharmAthene Biodefense Product Overview
10.5.3 PharmAthene Biodefense Product Market Performance
10.5.4 PharmAthene Business Overview
10.5.5 PharmAthene Recent Developments
10.6 Bavarian Nordic
10.6.1 Bavarian Nordic Basic Information
10.6.2 Bavarian Nordic Biodefense Product Overview
10.6.3 Bavarian Nordic Biodefense Product Market Performance
10.6.4 Bavarian Nordic Business Overview
10.6.5 Bavarian Nordic Recent Developments
10.7 SIGA Technologies
10.7.1 SIGA Technologies Basic Information
10.7.2 SIGA Technologies Biodefense Product Overview
10.7.3 SIGA Technologies Biodefense Product Market Performance
10.7.4 SIGA Technologies Business Overview
10.7.5 SIGA Technologies Recent Developments
10.8 Arbutus Biopharma
10.8.1 Arbutus Biopharma Basic Information
10.8.2 Arbutus Biopharma Biodefense Product Overview
10.8.3 Arbutus Biopharma Biodefense Product Market Performance
10.8.4 Arbutus Biopharma Business Overview
10.8.5 Arbutus Biopharma Recent Developments
10.9 DynPort Vaccine
10.9.1 DynPort Vaccine Basic Information
10.9.2 DynPort Vaccine Biodefense Product Overview
10.9.3 DynPort Vaccine Biodefense Product Market Performance
10.9.4 DynPort Vaccine Business Overview
10.9.5 DynPort Vaccine Recent Developments
10.10 Xoma Corporation
10.10.1 Xoma Corporation Basic Information
10.10.2 Xoma Corporation Biodefense Product Overview
10.10.3 Xoma Corporation Biodefense Product Market Performance
10.10.4 Xoma Corporation Business Overview
10.10.5 Xoma Corporation Recent Developments
10.11 Ichor Medical Systems
10.11.1 Ichor Medical Systems Basic Information
10.11.2 Ichor Medical Systems Biodefense Product Overview
10.11.3 Ichor Medical Systems Biodefense Product Market Performance
10.11.4 Ichor Medical Systems Business Overview
10.11.5 Ichor Medical Systems Recent Developments
10.12 Aeolus Pharmaceuticals
10.12.1 Aeolus Pharmaceuticals Basic Information
10.12.2 Aeolus Pharmaceuticals Biodefense Product Overview
10.12.3 Aeolus Pharmaceuticals Biodefense Product Market Performance
10.12.4 Aeolus Pharmaceuticals Business Overview
10.12.5 Aeolus Pharmaceuticals Recent Developments
10.13 Achaogen
10.13.1 Achaogen Basic Information
10.13.2 Achaogen Biodefense Product Overview
10.13.3 Achaogen Biodefense Product Market Performance
10.13.4 Achaogen Business Overview
10.13.5 Achaogen Recent Developments
10.14 Elusys Therapeutics
10.14.1 Elusys Therapeutics Basic Information
10.14.2 Elusys Therapeutics Biodefense Product Overview
10.14.3 Elusys Therapeutics Biodefense Product Market Performance
10.14.4 Elusys Therapeutics Business Overview
10.14.5 Elusys Therapeutics Recent Developments
10.15 Dynavax Technologies
10.15.1 Dynavax Technologies Basic Information
10.15.2 Dynavax Technologies Biodefense Product Overview
10.15.3 Dynavax Technologies Biodefense Product Market Performance
10.15.4 Dynavax Technologies Business Overview
10.15.5 Dynavax Technologies Recent Developments
10.16 Cleveland BioLabs
10.16.1 Cleveland BioLabs Basic Information
10.16.2 Cleveland BioLabs Biodefense Product Overview
10.16.3 Cleveland BioLabs Biodefense Product Market Performance
10.16.4 Cleveland BioLabs Business Overview
10.16.5 Cleveland BioLabs Recent Developments
10.17 Soligenix
10.17.1 Soligenix Basic Information
10.17.2 Soligenix Biodefense Product Overview
10.17.3 Soligenix Biodefense Product Market Performance
10.17.4 Soligenix Business Overview
10.17.5 Soligenix Recent Developments
10.18 Alnylam Pharmaceuticals
10.18.1 Alnylam Pharmaceuticals Basic Information
10.18.2 Alnylam Pharmaceuticals Biodefense Product Overview
10.18.3 Alnylam Pharmaceuticals Biodefense Product Market Performance
10.18.4 Alnylam Pharmaceuticals Business Overview
10.18.5 Alnylam Pharmaceuticals Recent Developments
11 BIODEFENSE MARKET FORECAST BY REGION
11.1 Global Biodefense Market Size Forecast
11.2 Global Biodefense Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biodefense Market Size Forecast by Country
11.2.3 Asia Pacific Biodefense Market Size Forecast by Region
11.2.4 South America Biodefense Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biodefense by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biodefense Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biodefense by Type (2026-2035)
12.1.2 Global Biodefense Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biodefense by Type (2026-2035)
12.2 Global Biodefense Market Forecast by Application (2026-2035)
12.2.1 Global Biodefense Sales (K MT) Forecast by Application
12.2.2 Global Biodefense Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biodefense Market Size by Type (M USD)
Table 4. Global Biodefense Market Size by Application
Table 5. Biodefense Market Size Comparison by Region (M USD)
Table 6. Global Biodefense Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biodefense Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biodefense Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biodefense Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2025)
Table 11. Global Market Biodefense Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biodefense Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biodefense Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biodefense Sales by Type (K MT)
Table 27. Global Biodefense Market Size by Type (M USD)
Table 28. Global Biodefense Sales (K MT) by Type (2020-2025)
Table 29. Global Biodefense Sales Market Share by Type (2020-2025)
Table 30. Global Biodefense Market Size (M USD) by Type (2020-2025)
Table 31. Global Biodefense Market Share by Type (2020-2025)
Table 32. Global Biodefense Price (USD/KG) by Type (2020-2025)
Table 33. Global Biodefense Sales (K MT) by Application
Table 34. Global Biodefense Market Size by Application
Table 35. Global Biodefense Sales by Application (2020-2025) & (K MT)
Table 36. Global Biodefense Sales Market Share by Application (2020-2025)
Table 37. Global Biodefense Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biodefense Market Share by Application (2020-2025)
Table 39. Global Biodefense Sales Growth Rate by Application (2020-2025)
Table 40. Global Biodefense Sales by Region (2020-2025) & (K MT)
Table 41. Global Biodefense Sales Market Share by Region (2020-2025)
Table 42. Global Biodefense Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biodefense Market Size by Region (2020-2025)
Table 44. North America Biodefense Sales by Country (2020-2025) & (K MT)
Table 45. North America Biodefense Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biodefense Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biodefense Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biodefense Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biodefense Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biodefense Sales by Country (2020-2025) & (K MT)
Table 51. South America Biodefense Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biodefense Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biodefense Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biodefense Production (K MT) by Region(2020-2025)
Table 55. Global Biodefense Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biodefense Revenue Market Share by Region (2020-2025)
Table 57. Global Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Emergent Biosolutions Basic Information
Table 63. Emergent Biosolutions Biodefense Product Overview
Table 64. Emergent Biosolutions Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Emergent Biosolutions Business Overview
Table 66. Emergent Biosolutions SWOT Analysis
Table 67. Emergent Biosolutions Recent Developments
Table 68. Hytest Basic Information
Table 69. Hytest Biodefense Product Overview
Table 70. Hytest Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Hytest Business Overview
Table 72. Hytest SWOT Analysis
Table 73. Hytest Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Biodefense Product Overview
Table 76. GSK Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Biodefense Product Overview
Table 82. Sanofi Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. PharmAthene Basic Information
Table 86. PharmAthene Biodefense Product Overview
Table 87. PharmAthene Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. PharmAthene Business Overview
Table 89. PharmAthene Recent Developments
Table 90. Bavarian Nordic Basic Information
Table 91. Bavarian Nordic Biodefense Product Overview
Table 92. Bavarian Nordic Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bavarian Nordic Business Overview
Table 94. Bavarian Nordic Recent Developments
Table 95. SIGA Technologies Basic Information
Table 96. SIGA Technologies Biodefense Product Overview
Table 97. SIGA Technologies Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. SIGA Technologies Business Overview
Table 99. SIGA Technologies Recent Developments
Table 100. Arbutus Biopharma Basic Information
Table 101. Arbutus Biopharma Biodefense Product Overview
Table 102. Arbutus Biopharma Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Arbutus Biopharma Business Overview
Table 104. Arbutus Biopharma Recent Developments
Table 105. DynPort Vaccine Basic Information
Table 106. DynPort Vaccine Biodefense Product Overview
Table 107. DynPort Vaccine Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. DynPort Vaccine Business Overview
Table 109. DynPort Vaccine Recent Developments
Table 110. Xoma Corporation Basic Information
Table 111. Xoma Corporation Biodefense Product Overview
Table 112. Xoma Corporation Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Xoma Corporation Business Overview
Table 114. Xoma Corporation Recent Developments
Table 115. Ichor Medical Systems Basic Information
Table 116. Ichor Medical Systems Biodefense Product Overview
Table 117. Ichor Medical Systems Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Ichor Medical Systems Business Overview
Table 119. Ichor Medical Systems Recent Developments
Table 120. Aeolus Pharmaceuticals Basic Information
Table 121. Aeolus Pharmaceuticals Biodefense Product Overview
Table 122. Aeolus Pharmaceuticals Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Aeolus Pharmaceuticals Business Overview
Table 124. Aeolus Pharmaceuticals Recent Developments
Table 125. Achaogen Basic Information
Table 126. Achaogen Biodefense Product Overview
Table 127. Achaogen Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Achaogen Business Overview
Table 129. Achaogen Recent Developments
Table 130. Elusys Therapeutics Basic Information
Table 131. Elusys Therapeutics Biodefense Product Overview
Table 132. Elusys Therapeutics Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Elusys Therapeutics Business Overview
Table 134. Elusys Therapeutics Recent Developments
Table 135. Dynavax Technologies Basic Information
Table 136. Dynavax Technologies Biodefense Product Overview
Table 137. Dynavax Technologies Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Dynavax Technologies Business Overview
Table 139. Dynavax Technologies Recent Developments
Table 140. Cleveland BioLabs Basic Information
Table 141. Cleveland BioLabs Biodefense Product Overview
Table 142. Cleveland BioLabs Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Cleveland BioLabs Business Overview
Table 144. Cleveland BioLabs Recent Developments
Table 145. Soligenix Basic Information
Table 146. Soligenix Biodefense Product Overview
Table 147. Soligenix Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Soligenix Business Overview
Table 149. Soligenix Recent Developments
Table 150. Alnylam Pharmaceuticals Basic Information
Table 151. Alnylam Pharmaceuticals Biodefense Product Overview
Table 152. Alnylam Pharmaceuticals Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Alnylam Pharmaceuticals Business Overview
Table 154. Alnylam Pharmaceuticals Recent Developments
Table 155. Global Biodefense Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Biodefense Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Biodefense Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Biodefense Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Biodefense Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Biodefense Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Biodefense Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Biodefense Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Biodefense Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Biodefense Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biodefense Market Size by Type (M USD)
Table 4. Global Biodefense Market Size by Application
Table 5. Biodefense Market Size Comparison by Region (M USD)
Table 6. Global Biodefense Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biodefense Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biodefense Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biodefense Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2025)
Table 11. Global Market Biodefense Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biodefense Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biodefense Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biodefense Sales by Type (K MT)
Table 27. Global Biodefense Market Size by Type (M USD)
Table 28. Global Biodefense Sales (K MT) by Type (2020-2025)
Table 29. Global Biodefense Sales Market Share by Type (2020-2025)
Table 30. Global Biodefense Market Size (M USD) by Type (2020-2025)
Table 31. Global Biodefense Market Share by Type (2020-2025)
Table 32. Global Biodefense Price (USD/KG) by Type (2020-2025)
Table 33. Global Biodefense Sales (K MT) by Application
Table 34. Global Biodefense Market Size by Application
Table 35. Global Biodefense Sales by Application (2020-2025) & (K MT)
Table 36. Global Biodefense Sales Market Share by Application (2020-2025)
Table 37. Global Biodefense Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biodefense Market Share by Application (2020-2025)
Table 39. Global Biodefense Sales Growth Rate by Application (2020-2025)
Table 40. Global Biodefense Sales by Region (2020-2025) & (K MT)
Table 41. Global Biodefense Sales Market Share by Region (2020-2025)
Table 42. Global Biodefense Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biodefense Market Size by Region (2020-2025)
Table 44. North America Biodefense Sales by Country (2020-2025) & (K MT)
Table 45. North America Biodefense Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biodefense Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biodefense Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biodefense Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biodefense Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biodefense Sales by Country (2020-2025) & (K MT)
Table 51. South America Biodefense Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biodefense Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biodefense Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biodefense Production (K MT) by Region(2020-2025)
Table 55. Global Biodefense Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biodefense Revenue Market Share by Region (2020-2025)
Table 57. Global Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biodefense Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Emergent Biosolutions Basic Information
Table 63. Emergent Biosolutions Biodefense Product Overview
Table 64. Emergent Biosolutions Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Emergent Biosolutions Business Overview
Table 66. Emergent Biosolutions SWOT Analysis
Table 67. Emergent Biosolutions Recent Developments
Table 68. Hytest Basic Information
Table 69. Hytest Biodefense Product Overview
Table 70. Hytest Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Hytest Business Overview
Table 72. Hytest SWOT Analysis
Table 73. Hytest Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Biodefense Product Overview
Table 76. GSK Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Biodefense Product Overview
Table 82. Sanofi Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. PharmAthene Basic Information
Table 86. PharmAthene Biodefense Product Overview
Table 87. PharmAthene Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. PharmAthene Business Overview
Table 89. PharmAthene Recent Developments
Table 90. Bavarian Nordic Basic Information
Table 91. Bavarian Nordic Biodefense Product Overview
Table 92. Bavarian Nordic Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bavarian Nordic Business Overview
Table 94. Bavarian Nordic Recent Developments
Table 95. SIGA Technologies Basic Information
Table 96. SIGA Technologies Biodefense Product Overview
Table 97. SIGA Technologies Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. SIGA Technologies Business Overview
Table 99. SIGA Technologies Recent Developments
Table 100. Arbutus Biopharma Basic Information
Table 101. Arbutus Biopharma Biodefense Product Overview
Table 102. Arbutus Biopharma Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Arbutus Biopharma Business Overview
Table 104. Arbutus Biopharma Recent Developments
Table 105. DynPort Vaccine Basic Information
Table 106. DynPort Vaccine Biodefense Product Overview
Table 107. DynPort Vaccine Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. DynPort Vaccine Business Overview
Table 109. DynPort Vaccine Recent Developments
Table 110. Xoma Corporation Basic Information
Table 111. Xoma Corporation Biodefense Product Overview
Table 112. Xoma Corporation Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Xoma Corporation Business Overview
Table 114. Xoma Corporation Recent Developments
Table 115. Ichor Medical Systems Basic Information
Table 116. Ichor Medical Systems Biodefense Product Overview
Table 117. Ichor Medical Systems Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Ichor Medical Systems Business Overview
Table 119. Ichor Medical Systems Recent Developments
Table 120. Aeolus Pharmaceuticals Basic Information
Table 121. Aeolus Pharmaceuticals Biodefense Product Overview
Table 122. Aeolus Pharmaceuticals Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Aeolus Pharmaceuticals Business Overview
Table 124. Aeolus Pharmaceuticals Recent Developments
Table 125. Achaogen Basic Information
Table 126. Achaogen Biodefense Product Overview
Table 127. Achaogen Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Achaogen Business Overview
Table 129. Achaogen Recent Developments
Table 130. Elusys Therapeutics Basic Information
Table 131. Elusys Therapeutics Biodefense Product Overview
Table 132. Elusys Therapeutics Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Elusys Therapeutics Business Overview
Table 134. Elusys Therapeutics Recent Developments
Table 135. Dynavax Technologies Basic Information
Table 136. Dynavax Technologies Biodefense Product Overview
Table 137. Dynavax Technologies Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Dynavax Technologies Business Overview
Table 139. Dynavax Technologies Recent Developments
Table 140. Cleveland BioLabs Basic Information
Table 141. Cleveland BioLabs Biodefense Product Overview
Table 142. Cleveland BioLabs Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Cleveland BioLabs Business Overview
Table 144. Cleveland BioLabs Recent Developments
Table 145. Soligenix Basic Information
Table 146. Soligenix Biodefense Product Overview
Table 147. Soligenix Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Soligenix Business Overview
Table 149. Soligenix Recent Developments
Table 150. Alnylam Pharmaceuticals Basic Information
Table 151. Alnylam Pharmaceuticals Biodefense Product Overview
Table 152. Alnylam Pharmaceuticals Biodefense Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Alnylam Pharmaceuticals Business Overview
Table 154. Alnylam Pharmaceuticals Recent Developments
Table 155. Global Biodefense Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Biodefense Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Biodefense Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Biodefense Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Biodefense Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Biodefense Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Biodefense Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Biodefense Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Biodefense Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Biodefense Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Biodefense Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Biodefense Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biodefense
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biodefense Market Size (M USD), 2025-2035
Figure 5. Global Biodefense Market Size (M USD) (2020-2035)
Figure 6. Global Biodefense Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biodefense Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biodefense Product Life Cycle
Figure 13. Biodefense Sales Share by Manufacturers in 2025
Figure 14. Global Biodefense Revenue Share by Manufacturers in 2025
Figure 15. Biodefense Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biodefense Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biodefense Revenue in 2025
Figure 18. Industry Chain Map of Biodefense
Figure 19. Global Biodefense Market PEST Analysis
Figure 20. Global Biodefense Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biodefense Market Share by Type
Figure 27. Sales Market Share of Biodefense by Type (2020-2025)
Figure 28. Sales Market Share of Biodefense by Type in 2025
Figure 29. Market Share of Biodefense by Type (2020-2025)
Figure 30. Market Share of Biodefense by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biodefense Market Share by Application
Figure 33. Global Biodefense Sales Market Share by Application (2020-2025)
Figure 34. Global Biodefense Sales Market Share by Application in 2025
Figure 35. Global Biodefense Market Share by Application (2020-2025)
Figure 36. Global Biodefense Market Share by Application in 2025
Figure 37. Global Biodefense Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biodefense Sales Market Share by Region (2020-2025)
Figure 39. Global Biodefense Market Size by Region (2020-2025)
Figure 40. North America Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biodefense Sales Market Share by Country in 2024
Figure 43. North America Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biodefense Market Size by Country in 2024
Figure 45. U.S. Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biodefense Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biodefense Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biodefense Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biodefense Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biodefense Sales Market Share by Country in 2024
Figure 53. Europe Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biodefense Market Size by Country in 2024
Figure 55. Germany Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biodefense Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biodefense Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biodefense Market Size by Region in 2024
Figure 68. China Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biodefense Sales and Growth Rate (K MT)
Figure 79. South America Biodefense Sales Market Share by Country in 2024
Figure 80. South America Biodefense Market Size and Growth Rate (M USD)
Figure 81. South America Biodefense Market Size by Country in 2024
Figure 82. Brazil Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biodefense Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biodefense Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biodefense Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biodefense Market Size by Region in 2024
Figure 92. Saudi Arabia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biodefense Production Market Share by Region (2020-2025)
Figure 103. North America Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biodefense Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biodefense Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biodefense Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biodefense Market Share Forecast by Type (2026-2035)
Figure 111. Global Biodefense Sales Forecast by Application (2026-2035)
Figure 112. Global Biodefense Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Biodefense
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biodefense Market Size (M USD), 2025-2035
Figure 5. Global Biodefense Market Size (M USD) (2020-2035)
Figure 6. Global Biodefense Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biodefense Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biodefense Product Life Cycle
Figure 13. Biodefense Sales Share by Manufacturers in 2025
Figure 14. Global Biodefense Revenue Share by Manufacturers in 2025
Figure 15. Biodefense Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biodefense Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biodefense Revenue in 2025
Figure 18. Industry Chain Map of Biodefense
Figure 19. Global Biodefense Market PEST Analysis
Figure 20. Global Biodefense Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biodefense Market Share by Type
Figure 27. Sales Market Share of Biodefense by Type (2020-2025)
Figure 28. Sales Market Share of Biodefense by Type in 2025
Figure 29. Market Share of Biodefense by Type (2020-2025)
Figure 30. Market Share of Biodefense by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biodefense Market Share by Application
Figure 33. Global Biodefense Sales Market Share by Application (2020-2025)
Figure 34. Global Biodefense Sales Market Share by Application in 2025
Figure 35. Global Biodefense Market Share by Application (2020-2025)
Figure 36. Global Biodefense Market Share by Application in 2025
Figure 37. Global Biodefense Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biodefense Sales Market Share by Region (2020-2025)
Figure 39. Global Biodefense Market Size by Region (2020-2025)
Figure 40. North America Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biodefense Sales Market Share by Country in 2024
Figure 43. North America Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biodefense Market Size by Country in 2024
Figure 45. U.S. Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biodefense Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biodefense Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biodefense Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biodefense Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biodefense Sales Market Share by Country in 2024
Figure 53. Europe Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biodefense Market Size by Country in 2024
Figure 55. Germany Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biodefense Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biodefense Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biodefense Market Size by Region in 2024
Figure 68. China Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biodefense Sales and Growth Rate (K MT)
Figure 79. South America Biodefense Sales Market Share by Country in 2024
Figure 80. South America Biodefense Market Size and Growth Rate (M USD)
Figure 81. South America Biodefense Market Size by Country in 2024
Figure 82. Brazil Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biodefense Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biodefense Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biodefense Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biodefense Market Size by Region in 2024
Figure 92. Saudi Arabia Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biodefense Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biodefense Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biodefense Production Market Share by Region (2020-2025)
Figure 103. North America Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biodefense Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biodefense Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biodefense Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biodefense Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biodefense Market Share Forecast by Type (2026-2035)
Figure 111. Global Biodefense Sales Forecast by Application (2026-2035)
Figure 112. Global Biodefense Market Share Forecast by Application (2026-2035)
